Intel® Black Belt Software Developer Dr. Clay Breshears Discusses Genome Sequencing & Bioinformatics
Intel® Black Belt Software Developer Dr.
Dr. Clay Breshears gives his thoughts about code modernization, and where he thinks that new technology is going.
Life Sciences simulation and modeling are breaking new ground in cancer research, drug development, patient screening, and visualization based on high-performance Intel® Xeon Phi™ processors and th
The ROME System was developed at the Dana Farber Cancer Institute and Harvard Medical School and funded in part by Intel® Parallel Computing Centers.
LAMMPS* 3D molecular dynamics simulations are used to analyze, visualize, and manipulate the high-resolution 3D molecular structure of proteins and simulate its movement and interaction.
This demo highlights research performed at Kyoto University Graduate School of Medicine with a dataset of more than 400 million proteins.
HPC resources add scale and power for clinical care and research that extends well beyond the drug development pipeline.
QIAGEN performs genome sequencing and analyzes the sequenced DNA to help identify patients who have variants of interest compared to a reference genome, and thus could have the protein that the cry
本演示重点介绍了京都大学医学研究生院的研究成果。该大学对超过 4 亿种蛋白质的数据集进行了研究。 此次演示使用相关的算法来分析化合物的虚拟库，并根据相关的化学和其他属性，预测哪些化合物可能适用于特定的蛋白质。其研究成果有助于更快地确定治疗方案。
得益于高性能英特尔® 至强融核™ 处理器和英特尔® 可扩展系统框架（英特尔® SSF），生命科学模拟和建模在癌症研究、药物发现、患者筛查以及可视化领域取得新的突破。这些演示展示了最新的科研技术和成果。